Ozempic overdose: why it isn't safe to calculate your own dose
Hand-measured doses have led to real overdoses. Why the errors happen, what the FDA reported and the signs that mean you should call your doctor.

When people try to use "less" of an injectable medicine, a dangerous practical problem comes up: measuring the dose. Between milliliters, milligrams, "units" on a syringe and clicks on a pen, mistakes are easy to make. The US Food and Drug Administration (FDA) has reported real semaglutide overdoses, of up to 20 times the intended dose, caused by exactly these kinds of mix-ups.
In short: injection pens are designed to deliver fixed doses, shown on the dose counter. Doses measured by hand, with syringes or by "counting clicks", are not validated and have led to overdoses. If you want a lower dose, ask your doctor to prescribe one of the approved doses.
What the FDA reported
On July 26, 2024, the FDA issued an alert about dosing errors with compounded semaglutide (prepared by pharmacies and supplied in vials, not pens). These products are often used for "microdosing":
- in most cases, patients gave themselves more than the prescribed dose, sometimes 5 to 20 times more;
- some patients were told to use 1 mL insulin syringes. Instead of 5 units (0.05 mL), they injected 50 units;
- there were also calculation errors made by health care professionals;
- the causes: inexperience with drawing the medicine from a vial and confusion between milliliters, milligrams and "units".
Reported consequences: nausea, vomiting, abdominal pain, fainting, headaches, migraines, dehydration, acute pancreatitis and gallstones. Some cases required hospitalization.
Why it's so easy to get it wrong
Three different units of measurement:
- milligrams (mg) show the amount of active substance (for example, 0.5 mg of semaglutide);
- milliliters (mL) show the volume of liquid;
- "units" on insulin syringes are volume markings (100 units = 1 mL).
The same dose in milligrams corresponds to a different volume depending on the product's concentration. Without the exact concentration, a number of mL or units doesn't tell you how much active substance you are injecting.
Very small volumes: GLP-1 doses are often just a few hundredths of a milliliter. A misplaced decimal point means a dose 10 times higher.
The injection pen: why a fixed dose matters
The original injection pens (Ozempic, Wegovy, Mounjaro) are calibrated to deliver only the doses shown on the dose counter. The manufacturer has not validated in-between doses obtained by "counting clicks" or other improvised methods.
"Click charts" for getting custom doses circulate online. They are not recognized by manufacturers or medicines regulators, and their accuracy has not been tested. We don't recommend them and won't reproduce them.
If you need a lower dose, the safe solution is for your doctor to prescribe one of the approved doses. For example, Mounjaro's official maintenance doses are 5, 10 and 15 mg, and for Wegovy the prescribing information provides for going back to the previous dose if significant side effects occur. See the minimum effective dose.
Signs of a possible overdose
Call your doctor or go to the emergency room if, after an injection, you have:
- severe nausea and vomiting that won't stop;
- you can't keep fluids down or have signs of dehydration (passing very little urine, dizziness, very dry mouth);
- severe dizziness or fainting;
- severe abdominal pain that doesn't go away, sometimes spreading to the back (possible pancreatitis; see rare side effects);
- if you also take insulin or a sulfonylurea: shakiness, sweating, confusion (possible hypoglycemia; the doses of these medicines may need adjusting when semaglutide is added).
🚨 For severe abdominal pain, difficulty breathing or loss of consciousness, call your local emergency number (911 in the US, 112 in Europe).
Because these medicines stay in the body for a long time (semaglutide for around a week), the effects of an overdose can last several days and need medical supervision.
To avoid mix-ups, an Ozempic tracker app such as Reko (partner app, iPhone) logs each dose and has a pen calculator for counting clicks, so you can check what you agreed with your prescriber.
Conclusion
Using a lower dose is not dangerous in itself, but how you get it matters enormously. Doses measured by hand or "by clicks" are not validated, and dosing errors have led to hospitalizations. The safe path is simple: talk to your doctor and use one of the approved doses, in the original pen. Here's how to approach the conversation.
Frequently asked questions
Can I use an insulin syringe for a lower dose of Ozempic? No. Ozempic comes in an injection pen calibrated for fixed doses. Drawing it out with a syringe is not an approved method, and the FDA has reported overdoses from errors of this kind.
What does "5 units" mean on an insulin syringe? On a 1 mL syringe, 100 units equal 1 mL, so 5 units equal 0.05 mL. The amount of active substance, however, depends on the product's concentration. That is exactly where the errors come from.
Is counting clicks on the pen safe? It is not a method validated by manufacturers. Pens are designed to deliver only the doses shown.
What should I do if I accidentally injected too much? Contact your doctor or go to the emergency room, especially if you develop severe vomiting, dehydration or severe abdominal pain. In an emergency, call your local emergency number (911 in the US, 112 in Europe).
How do I get a lower dose legitimately? Your doctor can prescribe one of the lower approved doses. Don't change the dose on your own.
Read also
Useful calculators
See the approved doses for each medicine, so you know what can be prescribed for you:
- Wegovy calculator: the approved dose schedule (0.25 → 2.4 mg).
- Mounjaro calculator: the approved doses (2.5 → 15 mg).
- Ozempic calculator: the dose schedule in type 2 diabetes.
- Saxenda calculator: the dose schedule for the daily injection.
The "GLP-1 dose" series
- The minimum effective GLP-1 dose: do you need the maximum dose?
- Mounjaro 5 mg vs 10 mg vs 15 mg: what the trials show
- Lowering the dose after weight loss: the SURMOUNT-MAINTAIN trial
- GLP-1 microdosing: what's real and what's marketing
- Ozempic overdose: why you shouldn't calculate your own dose
- Reducing your GLP-1 dose: how to talk to your doctor
Sources
- U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (July 26, 2024).
- Summary of Product Characteristics (SmPC): Wegovy, Mounjaro (European Medicines Agency).
Educational content, updated September 2026. It does not replace medical advice. Do not change the dose, frequency or way you take a medicine without the agreement of the doctor who prescribed it.
This article is for general information only and does not replace advice from your doctor or pharmacist. Do not start, stop or change a treatment without medical supervision.


